Pacemakers Articles & Analysis
51 news found
Boston: “According to the latest BCC Research study, the demand for EMI/RFI: Materials and Technologies is estimated to increase from $7.4 billion in 2023 to reach $9.2 billion by 2028, at a compound annual growth rate (CAGR) of 4.6% from 2023 through 2028.” This comprehensive report delves into the dynamic landscape of the EMI/RFI materials and technologies market, meticulously ...
Implicity’s AI-powered* platform allows healthcare professionals to better manage the growing streams of patient information produced by cardiac implantable electronic devices (CIEDs), such as pacemakers and implanted defibrillators. The solutions can also interpret data and automatically alert care teams when intervention is required. ...
These electrodes receive electrical impulses from a pacemaker placed at the abdominal level, which in turn receives the sequence of impulses that it must send to the epidural stimulator from an external computer, managed by the scientific researchers. ...
gammaCore is contraindicated for patients if they: Have an active implantable medical device, such as a pacemaker, hearing aid implant, or any implanted electronic device Have a metallic device, such as a stent, bone plate, or bone screw, implanted at or near the neck Are using another device at the same time (e.g., TENS Unit, muscle stimulator) or any portable electronic ...
gammaCore is contraindicated for patients if they: Have an active implantable medical device, such as a pacemaker, hearing aid implant, or any implanted electronic device Have a metallic device, such as a stent, bone plate, or bone screw, implanted at or near the neck Are using another device at the same time (e.g., TENS Unit, muscle stimulator) or any portable electronic ...
gammaCore is contraindicated for patients if they: Have an active implantable medical device, such as a pacemaker, hearing aid implant, or any implanted electronic device Have a metallic device, such as a stent, bone plate, or bone screw, implanted at or near the neck Are using another device at the same time (e.g., TENS Unit, muscle stimulator) or any portable electronic ...
The patient had come to the facility with shortness of breath and fatigue, which continued even after his pacemaker was adjusted. Following a transesophageal echocardiogram to assess the structure and function of the heart, the physicians discovered a mass in the right atrium, near the pacemaker wires. ...
gammaCore is contraindicated for patients if they: Have an active implantable medical device, such as a pacemaker, hearing aid implant, or any implanted electronic device Have a metallic device, such as a stent, bone plate, or bone screw, implanted at or near the neck Are using another device at the same time (e.g., TENS Unit, muscle stimulator) or any portable electronic ...
The FDA-approved ReShape® Integrated Dual Balloon System involves a non-surgical weight loss procedure that uses advanced interconnected balloon technology designed to take up room in the stomach to help people with a 30-40 BMI, and at least one co-morbidity, lose weight. vBloc® Neurometabolic Therapy, delivered by an FDA-approved pacemaker-like device called the vBloc ...
“The chronic and progressive nature of heart failure leaves many patients to face an increasingly challenging future as existing treatments, including medications and pacemaker devices, are not able to keep the disease at bay,” said Ulrich P. ...
gammaCore is contraindicated for patients if they: Have an active implantable medical device, such as a pacemaker, hearing aid implant, or any implanted electronic device Have a metallic device, such as a stent, bone plate, or bone screw, implanted at or near the neck Are using another device at the same time (e.g., TENS Unit, muscle stimulator) or any portable electronic ...
gammaCore is contraindicated for patients if they: Have an active implantable medical device, such as a pacemaker, hearing aid implant, or any implanted electronic device Have a metallic device, such as a stent, bone plate, or bone screw, implanted at or near the neck Are using another device at the same time (e.g., TENS Unit, muscle stimulator) or any portable electronic ...
“EBR’s WiSE leadless pacemaker technology is one of the most exciting cardiology technologies in development, and it is fantastic that more Australian investors can now back it,” says Dr. ...
Due to the advanced age and general poor health of the pacemaker population, the majority of the patients enrolled in the study had ISH, 23 patients in the treatment arm (88.5%) and 15 patients in the control arm (71.4%). ...
Complication Rates Associate with Pacemaker or ICD Generator Replacements and Upgrade Procedures. Circulation. 2010;122:1553-1561. ...
The editorial can be accessed here. Over 1.1 million pacemakers are implanted annually worldwide.1 Patients indicated for a pacemaker have a particularly high rate of elevated blood pressure with more than 70% of these patients suffering from hypertension.2 Based on data from the National Health and Nutrition Examination Survey (NHANES) III, it is estimated that ...
Avery Biomedical Devices (Commack, NY), the global leader in high reliability diaphragm pacemakers, announced that its new diaphragm pacemaker transmitter, Spirit, has earned FDA approval and is now being offered to patients using its pacing system. ...
Fourteen year-old Sedarius was recently featured on WSB-TV Atlanta as the first pediatric patient to receive surgery to implant a diaphragm pacemaker in the state of Georgia. Sedarius was diagnosed with CCHS when he was eight years old, and required a tracheotomy and ventilator to breathe while he slept. The Avery Breathing Pacemaker will allow him to breathe ...
For more information on the Avery Breathing Pacemaker and the viability of diaphragm pacing, please contact us for more ...
” MODERATO II is a European, prospective, multi-center, double-blind, randomized study of BackBeat CNT (n=26) vs. control (n=21) in patients with persistent hypertension (ASBP ≥130 mmHg and oSBP ≥ 140 mmHg) despite one or more anti-hypertensive medications and a pacemaker indication. Of the 21 control patients (treated with antihypertensive medications only, BackBeat ...